Health behavior change plan for adults with metabolic syndrome and kidney disease
Official title: The Effectiveness of a Theory-based Health Behaviour Change Intervention on Waist Circumference and Kidney Function in Patients of Metabolic Syndrome With Chronic Kidney Disease: A Pilot Randomised Controlled Trial
Run by Chinese University of Hong Kong · NCT06527768 · Data updated 2026-11-12
A 40-person study will test a theory-based behavior-change program to see if it can reduce waist size and protect kidney function over three months in Chinese adults with metabolic syndrome and chronic kidney disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | July 31, 2024 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT06527768 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Chinese adults 18+ with both MetS (per IDF criteria) and CKD, who can walk briskly, own a smartphone, and reside in Chengdu during the study.
✕Probably not a fit
Patients with very advanced kidney disease or those unable to participate in walking exercise may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study uses a two-arm, randomized design to compare a theory-based health behavior change intervention with usual care. Participants are adults with metabolic syndrome and chronic kidney disease, recruited in Chengdu, China. The primary outcome is change in waist circumference and kidney function (estimated GFR and urine albumin-to-creatinine ratio) over three months, with secondary measures including dietary behavior, physical activity, exercise capacity, and self-efficacy. Assessors are blinded to group assignment, and data are collected at baseline and after the intervention. A total of 40 participants (20 per arm) will be enrolled to assess feasibility and acceptability in addition to preliminary effectiveness.
Why it matters
Potential benefit: If successful, the program could help reduce central obesity and preserve kidney function in this high-risk population.
How similar studies have gone: Previous work suggests behavior-change interventions can improve health behaviors; this study tests a theory-based approach specifically in MetS with CKD, which remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants are 18 years old and above; * Participants have both diagnoses of MetS based on IDF clinical diagnostic criteria (WC for Chinese: ≥ 90 cm in men and ≥ 80 cm in women, and fulfils two items of the following: TG ≥ 1.7 mmol/L or treatment for hypertriglycerides, HDL-C\<1.03 mmol/L in men or \<1.29 mmol/L in women or treatment for low HDL-C, FG ≥5.6 mmol/L or previously diagnosed type 2 diabetes, and BP ≥ 130/85 mmHg or treatment for hypertension) and CKD; * No medical contraindications to exercise, including walking; * Participants are capable of understanding and providing informed consent; * Own a smartphone for accessing WeChat; * Being able to communicate in Chinese; * Stay in Chengdu during the study period. Exclusion Criteria: * Participants who cannot perform brisk walking exercise; * Participants who have already started dialysis or kidney transplant; * Current participation in another clinical trial related to health behaviour change or medical trial; * Participants who have doctor-diagnosed psychiatric illness; * Participants who have a cognitive impairment, which will be screened by the abbreviated mental test with a score lower than seven; * Adjustment of medication within half a year; * Participants who have performed regular planned exercise (Defined as at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of high-intensity aerobic activity per week, or a combination of moderate-intensity and high-intensity aerobic activity) within the past month.
Where it's running
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Lin Jia Yan
- Email: 1155185244@link.cuhk.edu.hk
- Phone: (852)5539 3204
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HAPA-based health behavior program for adults with metabolic syndrome and chronic kidney disease
A two-arm study will test a theory-based behavior-change program to see if it improves waist size, kidney function, and related health behaviors in adults with metabolic syndrome and chronic kidney disease.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.